VI Partners — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Sibylla Biotech develops PPI-FIT, a drug discovery technology that uses quantum physics and mathematical modeling to characterize protein folding pathways at atomic resolution.
AI & Machine LearningBiotechDeep TechTrento, IT
Emiliano Biasini(Co-founder)inPietro Faccioli(Co-founder)inGiovanni Spagnolli(Co-founder, CTO)inMaria Letizia Barreca(Co-founder)inGraziano Lolli(Co-founder)
Co-investors3B Future Health FundCDP Venture CapitalSeroba Life SciencesV-Bio VenturesVertis SGRClaris Ventures+1 more
Ledgy is a platform for managing non-cash compensation, including equity, deferred compensation, carried interest, pensions, and savings, with features for share plan administration, vesting schedules, cross-jurisdiction compliance reporting, and employee-facing dashboards.
FintechHR TechSaaSZürich, CH
Armon Bättig(Co-Founder & CEO)inYoko Spirig(Founder)inTimo Horstschäfer(Co-Founder & CTO)
Co-investorsCreathor VenturesNew Enterprise Associates (NEA)Sequoia Capitalb2ventureSpeedinvestVisionaries Club
Picterra provides a GeoAI platform that analyzes geospatial data from satellites, drones, and aerial imagery to deliver environmental intelligence for applications in agriculture, forestry, infrastructure, and energy sectors.
AgTechAI & Machine LearningClimate TechData & Infrastructure
Co-investorsAtlanticACE & Company
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.